Multimodal Management of Locally Advanced N2 Non-small Cell Lung Cancer

Posted On 2021-02-04 17:13:56

This special series on “Multimodal management of locally advanced N2 non-small cell lung cancer” is edited by Dr. Mariano Provencio.

Review Articles on Multimodal Management of Locally Advanced N2 Non-small Cell Lung Cancer
Mediastinal staging for non-small cell lung cancer
Virginia Leiro-Fernández, Alberto Fernández-Villar

Epidemiology of stage III lung cancer: frequency, diagnostic characteristics, and survival
Ana Casal-Mouriño, Alberto Ruano-Ravina, María Lorenzo-González, Ángeles Rodríguez-Martínez, Alexandra Giraldo-Osorio, Leonor Varela-Lema, Tara Pereiro-Brea, Juan Miguel Barros-Dios, Luis Valdés-Cuadrado, Mónica Pérez-Ríos

Minimal invasive surgery in locally advanced N2 non-small cell lung cancer
Ana Karina Patané

Systematic review of stereotactic body radiotherapy in stage III non-small cell lung cancer
Olwen Leaman Alcibar, Ernest Nadal, Inmaculada Romero Palomar, Arturo Navarro-Martin

Induction treatment in patients with stage III non-small cell lung cancer
Ramón Palmero, Noelia Vilariño, Arturo Navarro-Martín, Ernest Nadal

Salvage surgery after definitive chemoradiotherapy for patients with non-small cell lung cancer
Akira Hamada, Junichi Soh, Tetsuya Mitsudomi

Surgery after neoadjuvant immunotherapy in patients with resectable non-small cell lung cancer
Caroline Huynh, Logan A. Walsh, Jonathan D. Spicer

Prognostic factors in potentially resectable stage III non-small cell lung cancer receiving neoadjuvant treatment—a narrative review
Virginia Calvo, Carlos Aliaga, Carlos Carracedo, Mariano Provencio

Emerging biomarkers for neoadjuvant immune checkpoint inhibitors in operable non-small cell lung cancer
Monika Pradhan, Mathieu Chocry, Don L. Gibbons, Boris Sepesi, Tina Cascone

Neoadjuvant treatment of stage IIIA-N2 in EGFR-Mutant/ALK-rearranged non-small cell lung cancer
Roxana Reyes, Noemi Reguart


Disclosure:

The series “Multimodal management of locally advanced N2 non-small cell lung cancer” was commissioned by the editorial office, Translational Lung Cancer Research without any sponsorship or funding. Mariano Provencio served as the unpaid Guest Editor for the series.